Keenova Therapeutics plc Interest Expense Operating
Keenova Therapeutics plc reported Interest Expense Operating of $70.60 million for the 3-month period ending 2025-09-26, per its 10-Q filed 2025-11-10.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseOperating · last filed 2025-11-10
- Keenova Therapeutics plc interest expense operating for the quarter ending 2025-09-26 was $70.60M, a 19.66% increase year-over-year.
- Keenova Therapeutics plc interest expense operating for the quarter ending 2024-09-27 was $59.00M.
| Period end | Interest Expense Operating 3 month | Interest Expense Operating 9 month |
|---|---|---|
| 2025-09-26 | $70.60M 10-Q · filed 2025-11-10 | $136.00M 10-Q · filed 2025-11-10 |
| 2024-09-27 | $59.00M 10-Q · filed 2025-11-10 |